The Paul Marks Prize for Cancer Research recognizes a new generation of leaders in cancer research, who are making significant contributions to the understanding of cancer or are improving the treatment of the disease through basic or clinical research. The prize is intended to encourage young investigators who have a unique opportunity to help shape the future of cancer research.
The prize is now awarded to up to three investigators every other year. Nominees are required to be age 45 or younger on the date of the submission deadline. Recipients are selected by a panel of investigators from leading research institutions. The winners present their work at a scientific symposium at Memorial Sloan Kettering Cancer Center. Each receives a medal and they share a cash award of $150,000.
- About Paul Marks
The prize is named for Paul A. Marks, President Emeritus of Memorial Sloan Kettering Cancer Center.
- 2015 Prize Winners
The winners of the 2015 Paul Marks Prize are Bradley Bernstein, Howard Chang, and Daniel Durocher.
- 2013 Prize Winners
Simon J. Boulton, Levi A. Garraway, and Duojia (DJ) Pan
- 2011 Prize Winners
Scott A. Armstrong, Kornelia Polyak, and Victor E. Velculescu
- 2009 Prize Winners
Arul M. Chinnaiyan, Matthew L. Meyerson, and David M. Sabatini
- 2007 Prize Winners
Angelika Amon, Todd R. Golub, and Gregory J. Hannon
- 2005 Prize Winners
Tyler Jacks, Scott Lowe, and Jeff Wrana
- 2003 Prize Winners
Yuan Chang, John F.X. Diffley, and Nikola Pavletich
- 2001 Prize Winners
Titia de Lange, Stephen J. Elledge, William G. Kaelin Jr., and Xiaodong Wang
The nomination period for the 2017 Paul Marks Prize for Cancer Research will begin in late January 2017. Please stay tuned for more details. For more information, contact us at firstname.lastname@example.org